Cargando…
The diverse effects of pathogenic point mutations on ion channel activity of a gain-of-function polycystin-2
Autosomal dominant polycystic kidney disease is caused by mutations in PKD1 or PKD2 genes. The latter encodes polycystin-2 (PC2, also known as TRPP2), a member of the transient receptor potential ion channel family. Despite most pathogenic mutations in PKD2 being truncation variants, there are also...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192930/ https://www.ncbi.nlm.nih.gov/pubmed/37028763 http://dx.doi.org/10.1016/j.jbc.2023.104674 |
_version_ | 1785043733345992704 |
---|---|
author | Wang, Yan Wang, Zhifei Pavel, Mahmud Arif Ng, Courtney Kashyap, Parul Li, Bin Morais, Tiago D.C. Ulloa, Gabriella A. Yu, Yong |
author_facet | Wang, Yan Wang, Zhifei Pavel, Mahmud Arif Ng, Courtney Kashyap, Parul Li, Bin Morais, Tiago D.C. Ulloa, Gabriella A. Yu, Yong |
author_sort | Wang, Yan |
collection | PubMed |
description | Autosomal dominant polycystic kidney disease is caused by mutations in PKD1 or PKD2 genes. The latter encodes polycystin-2 (PC2, also known as TRPP2), a member of the transient receptor potential ion channel family. Despite most pathogenic mutations in PKD2 being truncation variants, there are also many point mutations, which cause small changes in protein sequences but dramatic changes in the in vivo function of PC2. How these mutations affect PC2 ion channel function is largely unknown. In this study, we systematically tested the effects of 31 point mutations on the ion channel activity of a gain-of-function PC2 mutant, PC2_F604P, expressed in Xenopus oocytes. The results show that all mutations in the transmembrane domains and channel pore region, and most mutations in the extracellular tetragonal opening for polycystins domain, are critical for PC2_F604P channel function. In contrast, the other mutations in the tetragonal opening for polycystins domain and most mutations in the C-terminal tail cause mild or no effects on channel function as assessed in Xenopus oocytes. To understand the mechanism of these effects, we have discussed possible conformational consequences of these mutations based on the cryo-EM structures of PC2. The results help gain insight into the structure and function of the PC2 ion channel and the molecular mechanism of pathogenesis caused by these mutations. |
format | Online Article Text |
id | pubmed-10192930 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Society for Biochemistry and Molecular Biology |
record_format | MEDLINE/PubMed |
spelling | pubmed-101929302023-05-19 The diverse effects of pathogenic point mutations on ion channel activity of a gain-of-function polycystin-2 Wang, Yan Wang, Zhifei Pavel, Mahmud Arif Ng, Courtney Kashyap, Parul Li, Bin Morais, Tiago D.C. Ulloa, Gabriella A. Yu, Yong J Biol Chem Research Article Autosomal dominant polycystic kidney disease is caused by mutations in PKD1 or PKD2 genes. The latter encodes polycystin-2 (PC2, also known as TRPP2), a member of the transient receptor potential ion channel family. Despite most pathogenic mutations in PKD2 being truncation variants, there are also many point mutations, which cause small changes in protein sequences but dramatic changes in the in vivo function of PC2. How these mutations affect PC2 ion channel function is largely unknown. In this study, we systematically tested the effects of 31 point mutations on the ion channel activity of a gain-of-function PC2 mutant, PC2_F604P, expressed in Xenopus oocytes. The results show that all mutations in the transmembrane domains and channel pore region, and most mutations in the extracellular tetragonal opening for polycystins domain, are critical for PC2_F604P channel function. In contrast, the other mutations in the tetragonal opening for polycystins domain and most mutations in the C-terminal tail cause mild or no effects on channel function as assessed in Xenopus oocytes. To understand the mechanism of these effects, we have discussed possible conformational consequences of these mutations based on the cryo-EM structures of PC2. The results help gain insight into the structure and function of the PC2 ion channel and the molecular mechanism of pathogenesis caused by these mutations. American Society for Biochemistry and Molecular Biology 2023-04-05 /pmc/articles/PMC10192930/ /pubmed/37028763 http://dx.doi.org/10.1016/j.jbc.2023.104674 Text en © 2023 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Research Article Wang, Yan Wang, Zhifei Pavel, Mahmud Arif Ng, Courtney Kashyap, Parul Li, Bin Morais, Tiago D.C. Ulloa, Gabriella A. Yu, Yong The diverse effects of pathogenic point mutations on ion channel activity of a gain-of-function polycystin-2 |
title | The diverse effects of pathogenic point mutations on ion channel activity of a gain-of-function polycystin-2 |
title_full | The diverse effects of pathogenic point mutations on ion channel activity of a gain-of-function polycystin-2 |
title_fullStr | The diverse effects of pathogenic point mutations on ion channel activity of a gain-of-function polycystin-2 |
title_full_unstemmed | The diverse effects of pathogenic point mutations on ion channel activity of a gain-of-function polycystin-2 |
title_short | The diverse effects of pathogenic point mutations on ion channel activity of a gain-of-function polycystin-2 |
title_sort | diverse effects of pathogenic point mutations on ion channel activity of a gain-of-function polycystin-2 |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192930/ https://www.ncbi.nlm.nih.gov/pubmed/37028763 http://dx.doi.org/10.1016/j.jbc.2023.104674 |
work_keys_str_mv | AT wangyan thediverseeffectsofpathogenicpointmutationsonionchannelactivityofagainoffunctionpolycystin2 AT wangzhifei thediverseeffectsofpathogenicpointmutationsonionchannelactivityofagainoffunctionpolycystin2 AT pavelmahmudarif thediverseeffectsofpathogenicpointmutationsonionchannelactivityofagainoffunctionpolycystin2 AT ngcourtney thediverseeffectsofpathogenicpointmutationsonionchannelactivityofagainoffunctionpolycystin2 AT kashyapparul thediverseeffectsofpathogenicpointmutationsonionchannelactivityofagainoffunctionpolycystin2 AT libin thediverseeffectsofpathogenicpointmutationsonionchannelactivityofagainoffunctionpolycystin2 AT moraistiagodc thediverseeffectsofpathogenicpointmutationsonionchannelactivityofagainoffunctionpolycystin2 AT ulloagabriellaa thediverseeffectsofpathogenicpointmutationsonionchannelactivityofagainoffunctionpolycystin2 AT yuyong thediverseeffectsofpathogenicpointmutationsonionchannelactivityofagainoffunctionpolycystin2 AT wangyan diverseeffectsofpathogenicpointmutationsonionchannelactivityofagainoffunctionpolycystin2 AT wangzhifei diverseeffectsofpathogenicpointmutationsonionchannelactivityofagainoffunctionpolycystin2 AT pavelmahmudarif diverseeffectsofpathogenicpointmutationsonionchannelactivityofagainoffunctionpolycystin2 AT ngcourtney diverseeffectsofpathogenicpointmutationsonionchannelactivityofagainoffunctionpolycystin2 AT kashyapparul diverseeffectsofpathogenicpointmutationsonionchannelactivityofagainoffunctionpolycystin2 AT libin diverseeffectsofpathogenicpointmutationsonionchannelactivityofagainoffunctionpolycystin2 AT moraistiagodc diverseeffectsofpathogenicpointmutationsonionchannelactivityofagainoffunctionpolycystin2 AT ulloagabriellaa diverseeffectsofpathogenicpointmutationsonionchannelactivityofagainoffunctionpolycystin2 AT yuyong diverseeffectsofpathogenicpointmutationsonionchannelactivityofagainoffunctionpolycystin2 |